prof. dr. J.A. (Jourik) Gietema

Professor

prof. dr. J.A. (Jourik) Gietema
E-mail:
j.a.gietema umcg.nl

Research

  1. 2019
  2. Jacobse, J. N., Steggink, L., Sonke, G. S., Schaapveld, M., Hummel, Y. M., Steenbruggen, T. G., ... van Leeuwen, F. E. (2019). Myocardial dysfunction in long-term breast cancer survivors treated at ages 40–50 years. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.1610
  3. Hurley, R. M., Hendrickson, A. E. W., Visscher, D. W., Ansel, P., Harrell, M. I., Wagner, J. M., ... Kaufmann, S. H. (2019). 53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer. Gynecologic Oncology, 153(1), 127-134. https://doi.org/10.1016/j.ygyno.2019.01.015
  4. Jacobse, J. N., Duane, F. K., Boekel, N. B., Schaapveld, M., Hauptmann, M., Hooning, M. J., ... Taylor, C. W. (2019). Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors. International Journal of Radiation Oncology Biology Physics, 103(3), 595-604. https://doi.org/10.1016/j.ijrobp.2018.10.025
  5. 2018
  6. Groot, H. J., Gietema, J. A., Aleman, B. M. P., Incrocci, L., de Wit, R., Witjes, J. A., ... Schaapveld, M. (2018). Risk of diabetes after para-aortic radiation for testicular cancer. British Journal of Cancer, 119(7), 901-907. https://doi.org/10.1038/s41416-018-0248-x
  7. Groot, H. J., Lubberts, S., de Wit, R., Witjes, J. A., Kerst, J. M., de Jong, I. J., ... Schaapveld, M. (2018). Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era. Journal of Clinical Oncology, 36(24), 2504-2513. https://doi.org/10.1200/JCO.2017.77.4174
  8. Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C., Cathomas, R., ... Horwich, A. (2018). ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Annals of Oncology, 29(8), 1658-1686. https://doi.org/10.1093/annonc/mdy217
  9. 2017
  10. 2016
Previous 1 2 3 4 5 Next

ID: 75154